
|
An ISET Healthcare portal for medical professionals in the Middle East Friday 3rd September 2010
Featured:
-
By: imran on September 3, 2010
 In the war against antibiotics, bacteria aren’t selfish. According to a new report from Howard Hughes Medical Institute (HHMI) researchers, a handful of resistant pathogens can protect an entire colony. Prevailing wisdom held that antibiotic resistance works only on an individual level: a bacterium acquires a genetic mutation that confers protection against a drug, allowing [...]
-
By: imran on September 3, 2010
 Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all. Building on existing knowledge, a study published in the September edition of the Journal of Thoracic Oncology (JTO), analyzed the usefulness of adjuvant chemotherapy [...]
-
By: imran on September 3, 2010
 Research links chemical in widely consumed foods to skin cancer The September cover story of the nation’s leading cancer journal, “Cancer Research,” features a new study from The Hormel Institute, University of Minnesota, that links capsaicin, a component of chili peppers, to skin cancer. While the molecular mechanisms of the cancer-promoting effects of capsaicin are [...]
-
By: imran on September 3, 2010
 German scientists from Tübingen and Mainz have developed a blood test that can reliably detect gene doping even after 56 days. Scientists at the universities in Tübingen and Mainz have developed a test that can provide conclusive proof of gene doping. “For the first time, a direct method is now available that uses conventional blood [...]
-
By: imran on September 3, 2010
 Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, “New Thermal Sensitive Carboplatin Liposomes for Cancer”. This funding will support the Company’s efforts to develop its [...]
-
By: imran on September 3, 2010
 Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance. The discovery could lead to development of a simple dietary remedy for many of the more than 23 million Americans suffering from diabetes and other [...]
-
By: imran on September 3, 2010
 Stem Cell Assurance, Inc. a leader in stem cell collection and storage services for personal applications ranging from breast augmentation and facial rejuvenation procedures to Stem Cellutrition™ (www.stemcellutrition.com) skincare products, today announced a $1M agreement with a private funding source. This source will provide consulting services as it relates to securing loans, letters of credit, [...]
-
By: imran on September 2, 2010
 Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI). Results of this study will be published in the September issue of Cancer Prevention Research, a journal of the American Association for Cancer Research. Scott [...]
-
By: imran on September 2, 2010
 Detection of circulating and disseminated tumor cells in blood is a promising methodology to diagnose cancer dissemination or to follow up cancer patients during therapy. Today, the detection analyses of these cells are performed in medical laboratories requiring labor intensive, expensive and time-consuming sample processing and cell isolation steps. A full tumor cell detection analysis [...]
-
By: imran on September 2, 2010
 Adding a variety of vegetables to one’s diet may help decrease the chance of getting lung cancer, and adding a variety of fruits and vegetables may decrease the risk of squamous cell lung cancer, especially among smokers. Study results are published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer [...]
Written By: imran on September 3, 2010
Single nucleotide polymorphisms (SNPs) are DNA sequence variations that occur when a single nucleotide in the genome sequence is altered. Prior research suggested an association between SNPs in a gene that encodes aspects of the brain’s gamma-amino butyric acid (GABA)-A receptors (the GABRA2 gene) and alcohol dependence. A study of responses to the aromas of [...]
Written By: imran on September 3, 2010
A molecular test designed to easily diagnose tuberculosis (TB) and detect a drug-resistant form of the bacterium that causes TB can provide much more specific, sensitive and rapid results than currently available TB diagnostics, according to a new study in the New England Journal of Medicine. In a test involving 1,730 patients with suspected drug-sensitive [...]
Written By: imran on September 3, 2010
Counterfeiting of drugs is a huge industry with an annual turnover of more than SEK 500 billion. In Africa the situation is extremely serious. Half of the malaria medication sold there could be ineffective or even harmful. Researchers from Lund and the UK have now developed a technique that could resolve the situation. In two [...]
Written By: imran on September 3, 2010
A cell devotes a significant amount of effort to maintaining the stability of its genome, preventing the sorts of chromosomal rearrangements characteristic of many cancers. Assays that measure the rate of gross chromosomal rearrangements (GCRs) are needed in order to understand the individual genes and the different pathways that suppress genomic instability. In the September [...]
Written By: imran on September 3, 2010
In the war against antibiotics, bacteria aren’t selfish. According to a new report from Howard Hughes Medical Institute (HHMI) researchers, a handful of resistant pathogens can protect an entire colony. Prevailing wisdom held that antibiotic resistance works only on an individual level: a bacterium acquires a genetic mutation that confers protection against a drug, allowing [...]
Written By: imran on September 3, 2010
When it comes to the mechanics of the human immune system, we are all more alike than previously thought, according to a new study by scientists at Fred Hutchinson Cancer Research Center. This finding has significant implications for developing new ways to detect, diagnose and treat cancer and diseases of the immune system, according to [...]
Written By: imran on September 3, 2010
The existence of chronic Lyme disease is an issue of sharp debate within the medical community. Some health care workers who call themselves “Lyme literate” insist that chronic Lyme disease is frequently diagnosed and treated by primary care physicians. Others, however, including the American Academy of Pediatrics and the Infectious Diseases Society of America, state [...]
Written By: imran on September 3, 2010
Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all. Building on existing knowledge, a study published in the September edition of the Journal of Thoracic Oncology (JTO), analyzed the usefulness of adjuvant chemotherapy [...]
Written By: imran on September 3, 2010
Insomnia and other sleep disorders are very common, yet are not generally well understood by doctors and other health care professionals. Now the British Association for Psychopharmacology (BAP) has released up-to-the-minute guidelines in the Journal of Psychopharmacology, published by SAGE, to guide psychiatrists and physicians caring for those with sleep problems. BAP members, representative clinicians [...]
Written By: imran on September 3, 2010
New bone analysis shows ancient Nubians consumed tetracycline, most likely in their beer A chemical analysis of the bones of ancient Nubians shows that they were regularly consuming tetracycline, most likely in their beer. The finding is the strongest evidence yet that the art of making antibiotics, which officially dates to the discovery of penicillin [...]
Written By: imran on September 3, 2010
Research links chemical in widely consumed foods to skin cancer The September cover story of the nation’s leading cancer journal, “Cancer Research,” features a new study from The Hormel Institute, University of Minnesota, that links capsaicin, a component of chili peppers, to skin cancer. While the molecular mechanisms of the cancer-promoting effects of capsaicin are [...]
Written By: imran on September 3, 2010
German scientists from Tübingen and Mainz have developed a blood test that can reliably detect gene doping even after 56 days. Scientists at the universities in Tübingen and Mainz have developed a test that can provide conclusive proof of gene doping. “For the first time, a direct method is now available that uses conventional blood [...]
Written By: imran on September 3, 2010
The aluminium content of a range of the most popular brands of infant formulas remains high, and particularly so for a product designed for preterm infants and a soya-based product designed for infants with cow’s milk intolerances and allergies, researchers have found. A study by a team at Keele University in Staffordshire, led by Dr [...]
Written By: imran on September 3, 2010
Cigarette smoke shuts off a key enzyme in airways that regulates the body’s response to inflammation, according to findings from the University of Alabama at Birmingham published online today at Science Express. The UAB researchers say smoke inhibits the enzyme, called Leukotriene A4 Hydrolase (LTA4H), causing it to fail in its job of shutting down [...]
Written By: imran on September 3, 2010
Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, “New Thermal Sensitive Carboplatin Liposomes for Cancer”. This funding will support the Company’s efforts to develop its [...]
|
|
|